How the Peptide Substance P Binds to Its Pain and Nausea Receptor: New Details from NMR Imaging

What the researchers found

Using 19F-NMR spectroscopy with fluorine probes placed at five positions along Substance P (positions 0, 3, 5, 7, and 8), researchers found that the C-terminal hexapeptide segment is rigidly anchored within NK1R's orthosteric binding pocket, while the N-terminal pentapeptide segment remains flexible and solvent-exposed when bound. Critically, transient interactions between the side chains of Lys3 and Gln5 in Substance P with sites on NK1R significantly impact the peptide's functional potency, as confirmed by cAMP function assays. This reveals that dynamic, short-lived molecular contacts — invisible to static structural methods like cryo-EM — play important roles in peptide-receptor signaling.

Why it matters

NK1R antagonists are already used clinically for treating nausea (e.g., aprepitant for chemotherapy-induced nausea). Understanding exactly how Substance P binds and activates NK1R at the molecular level could lead to better-designed drugs that more precisely block this interaction, potentially improving treatments for pain, nausea, inflammation, and neurological disorders.

How the study worked

The researchers used 19F-NMR spectroscopy, introducing a fluorinated amino acid probe (mtfF) at five positions in Substance P. They observed the peptide in three states: free in solution, bound to lipid micelles, and bound to micelle-solubilized NK1R. They measured exchange rates between all states and complemented the NMR data with cyclic AMP functional assays to assess how specific interactions affected receptor activation.

What this study cannot tell us

The study was conducted in vitro using micelle-solubilized receptor rather than a native cell membrane environment. The NMR approach required introducing modified amino acids into the peptide, which could subtly alter binding behavior despite functional validation. Results are specific to the NK1R-Substance P system and may not directly generalize to other peptide-GPCR pairs.

How to read the evidence

This is an original structural biology study published in the Journal of the American Chemical Society, using rigorous NMR methodology with functional validation through cAMP assays. The evidence is strong for its specific findings about molecular interactions, though it is in vitro and mechanistic rather than clinical.

When this study was published

Published in 2025, this study uses cutting-edge NMR techniques to reveal molecular details that previous cryo-EM structures could not capture, representing the current frontier of peptide-receptor structural biology.

The bigger picture

G protein-coupled receptors (GPCRs) like NK1R are targets of roughly one-third of all approved drugs. This study demonstrates that static structural snapshots from cryo-EM miss functionally important dynamic interactions in peptide-GPCR binding. The finding that transient contacts at the flexible end of Substance P influence signaling potency could reshape how we think about peptide-receptor interactions across the entire GPCR family.

Questions still open

• Could targeting the dynamic N-terminal interactions of Substance P lead to more selective NK1R modulators?
• Do other neuropeptides show similar flexible-rigid binding patterns with their GPCR targets?
• How do existing NK1R antagonists like aprepitant interact with the same binding regions identified in this study?

Common questions

Read the original research

Human Substance P Interactions with G Protein-Coupled Receptor NK1R Observed by NMR in Solution.

Journal of the American Chemical Society, 147(48), 44114-44122

Citation

Ge, Haoyi; Yang, Lingyun; Chen, Changran; Xu, Yuxin; Liu, Dongsheng; Wüthrich, Kurt. (2025). Human Substance P Interactions with G Protein-Coupled Receptor NK1R Observed by NMR in Solution.. Journal of the American Chemical Society, 147(48), 44114-44122. https://doi.org/10.1021/jacs.5c12553